Nephropathy in Type 2 Diabetes Mellitus
Diabetic nephropathy is kidney damage that develops when persistently high blood sugar injures the tiny filtering vessels inside the kidneys. It is a serious complication of type 2 diabetes mellitus and one of the most common causes of end-stage kidney disease, as type 2 diabetes rates have risen sharply worldwide over the past two decades.
Key points
- High blood sugar over time injures the kidneys’ tiny filtering vessels, making this one of the leading causes of end-stage kidney disease.
- Blocking the renin-angiotensin system with agents such as irbesartan cuts protein leakage into the urine and slows further kidney damage.
- Tight blood sugar and blood pressure control, alongside limiting dietary sodium and protein, are central to slowing its progression.
How nephropathy in type 2 diabetes is managed
The central aim is slowing the decline in kidney function. Tight glucose control and blood pressure management are the cornerstones. Medicines that block the renin-angiotensin system, including irbesartan and related agents, reduce protein leakage into the urine (proteinuria) and slow structural damage to the kidneys. These agents are also used to manage the raised blood pressure that frequently accompanies kidney disease; you can find related treatments in the heart and blood pressure category. Dietary changes, particularly limiting sodium and protein intake, support these effects. Regular monitoring of kidney function tests (eGFR, creatinine) and urine protein helps guide treatment adjustments over time.
Any sudden drop in urine output, significant swelling of the legs, or marked shortness of breath should be assessed promptly.